Cargando…

Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer

Bright/ARID3A is a nuclear matrix-associated transcription factor that stimulates immunoglobulin heavy chain (IgH) expression and Cyclin E1/E2F-dependent cell cycle progression. Bright positively activates IgH transcriptional initiation by binding to ATC-rich P sites within nuclear matrix attachment...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Danjuan, Ippolito, Gregory C, Zong, Rui-Ting, Bryant, James, Koslovsky, Janet, Tucker, Philip
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852116/
https://www.ncbi.nlm.nih.gov/pubmed/17386101
http://dx.doi.org/10.1186/1476-4598-6-23
_version_ 1782133014757638144
author Lin, Danjuan
Ippolito, Gregory C
Zong, Rui-Ting
Bryant, James
Koslovsky, Janet
Tucker, Philip
author_facet Lin, Danjuan
Ippolito, Gregory C
Zong, Rui-Ting
Bryant, James
Koslovsky, Janet
Tucker, Philip
author_sort Lin, Danjuan
collection PubMed
description Bright/ARID3A is a nuclear matrix-associated transcription factor that stimulates immunoglobulin heavy chain (IgH) expression and Cyclin E1/E2F-dependent cell cycle progression. Bright positively activates IgH transcriptional initiation by binding to ATC-rich P sites within nuclear matrix attachment regions (MARs) flanking the IgH intronic enhancer (Eμ). Over-expression of Bright in cultured B cells was shown to correlate with DNase hypersensitivity of Eμ. We report here further efforts to analyze Bright-mediated Eμ enhancer activation within the physiological constraints of chromatin. A system was established in which VH promoter-driven in vitro transcription on chromatin- reconstituted templates was responsive to Eμ. Bright assisted in blocking the general repression caused by nucleosome assembly but was incapable of stimulating transcription from prebound nucleosome arrays. In vitro transcriptional derepression by Bright was enhanced on templates in which Eμ is flanked by MARs and was inhibited by competition with high affinity Bright binding (P2) sites. DNase hypersensitivity of chromatin-reconstituted Eμ was increased when prepackaged with B cell nuclear extract supplemented with Bright. These results identify Bright as a contributor to accessibility of the IgH enhancer.
format Text
id pubmed-1852116
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18521162007-04-14 Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer Lin, Danjuan Ippolito, Gregory C Zong, Rui-Ting Bryant, James Koslovsky, Janet Tucker, Philip Mol Cancer Research Bright/ARID3A is a nuclear matrix-associated transcription factor that stimulates immunoglobulin heavy chain (IgH) expression and Cyclin E1/E2F-dependent cell cycle progression. Bright positively activates IgH transcriptional initiation by binding to ATC-rich P sites within nuclear matrix attachment regions (MARs) flanking the IgH intronic enhancer (Eμ). Over-expression of Bright in cultured B cells was shown to correlate with DNase hypersensitivity of Eμ. We report here further efforts to analyze Bright-mediated Eμ enhancer activation within the physiological constraints of chromatin. A system was established in which VH promoter-driven in vitro transcription on chromatin- reconstituted templates was responsive to Eμ. Bright assisted in blocking the general repression caused by nucleosome assembly but was incapable of stimulating transcription from prebound nucleosome arrays. In vitro transcriptional derepression by Bright was enhanced on templates in which Eμ is flanked by MARs and was inhibited by competition with high affinity Bright binding (P2) sites. DNase hypersensitivity of chromatin-reconstituted Eμ was increased when prepackaged with B cell nuclear extract supplemented with Bright. These results identify Bright as a contributor to accessibility of the IgH enhancer. BioMed Central 2007-03-26 /pmc/articles/PMC1852116/ /pubmed/17386101 http://dx.doi.org/10.1186/1476-4598-6-23 Text en Copyright © 2007 Lin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lin, Danjuan
Ippolito, Gregory C
Zong, Rui-Ting
Bryant, James
Koslovsky, Janet
Tucker, Philip
Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer
title Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer
title_full Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer
title_fullStr Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer
title_full_unstemmed Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer
title_short Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer
title_sort bright/arid3a contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852116/
https://www.ncbi.nlm.nih.gov/pubmed/17386101
http://dx.doi.org/10.1186/1476-4598-6-23
work_keys_str_mv AT lindanjuan brightarid3acontributestochromatinaccessibilityoftheimmunoglobulinheavychainenhancer
AT ippolitogregoryc brightarid3acontributestochromatinaccessibilityoftheimmunoglobulinheavychainenhancer
AT zongruiting brightarid3acontributestochromatinaccessibilityoftheimmunoglobulinheavychainenhancer
AT bryantjames brightarid3acontributestochromatinaccessibilityoftheimmunoglobulinheavychainenhancer
AT koslovskyjanet brightarid3acontributestochromatinaccessibilityoftheimmunoglobulinheavychainenhancer
AT tuckerphilip brightarid3acontributestochromatinaccessibilityoftheimmunoglobulinheavychainenhancer